Ensign Peak Advisors Portfolio holdings
AUM
$58.4B
This Quarter Return
+10.03%
1 Year Return
+23.83%
3 Year Return
+106.64%
5 Year Return
+193.2%
10 Year Return
–
AUM
$39.6B
AUM Growth
+$39.6B
(+7.6%)
Cap. Flow
+$1.53B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
25.25%
Holding
1,779
New
108
Increased
534
Reduced
493
Closed
39
Top Buys
| 1 |
Apple
AAPL
|
$1.65B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$142M |
| 3 |
Meta Platforms (Facebook)
META
|
$56.7M |
| 4 |
Analog Devices
ADI
|
$48.6M |
| 5 |
Amazon
AMZN
|
$47.7M |
Top Sells
| 1 |
Intel
INTC
|
$88.4M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$67.8M |
| 3 |
Johnson & Johnson
JNJ
|
$64.6M |
| 4 |
RB Global
RBA
|
$62.4M |
| 5 |
Merck
MRK
|
$45.5M |
Sector Composition
| 1 | Technology | 23.91% |
| 2 | Healthcare | 15.94% |
| 3 | Financials | 12.41% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Wabash National
WNC
$450M
| $612K | ﹤0.01% |
51,171
| – | – |
|
1477
Tanger
SKT
$3.84B
| $611K | ﹤0.01% |
101,350
| – | – |
|
1478
Oxford Industries
OXM
$632M
| $604K | ﹤0.01% |
14,965
| – | – |
|
1479
Syndax Pharmaceuticals
SNDX
$1.37B
| $604K | ﹤0.01% |
40,977
+23,023
| +128% | +$339K |
|
1480
Enova International
ENVA
$2.98B
| $603K | ﹤0.01% |
36,800
| – | – |
|
1481
Corcept Therapeutics
CORT
$7.46B
| $600K | ﹤0.01% |
34,500
| – | – |
|
1482
ATN International
ATNI
$241M
| $597K | ﹤0.01% |
11,898
| – | – |
|
1483
Repare Therapeutics
RPTX
$73M
| $597K | ﹤0.01% |
19,400
+17,400
| +870% | +$535K |
|
1484
Akero Therapeutics
AKRO
$3.62B
| $595K | ﹤0.01% |
19,321
-7,881
| -29% | -$243K |
|
1485
BCE
BCE
$22.9B
| $592K | ﹤0.01% |
13,916
-9,456
| -40% | -$402K |
|
1486
OneSpan
OSPN
$578M
| $591K | ﹤0.01% |
28,219
| – | – |
|
1487
Ubiquiti
UI
$32.7B
| $590K | ﹤0.01% |
3,540
+2,490
| +237% | +$415K |
|
1488
Matthews International
MATW
$741M
| $588K | ﹤0.01% |
26,301
| – | – |
|
1489
AAR Corp
AIR
$2.71B
| $587K | ﹤0.01% |
31,223
| – | – |
|
1490
Deutsche Bank
DB
$66.8B
| $586K | ﹤0.01% |
72,650
-11,350
| -14% | -$91.6K |
|
1491
OFG Bancorp
OFG
$1.97B
| $586K | ﹤0.01% |
46,999
| – | – |
|
|
DRNA
1492
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $586K | ﹤0.01% |
+32,573
| New | +$586K |
|
1493
PBF Energy
PBF
$3.2B
| $582K | ﹤0.01% |
102,317
| – | – |
|
1494
3D Systems Corporation
DDD
$264M
| $576K | ﹤0.01% |
117,343
| – | – |
|
1495
Adeia
ADEA
$1.66B
| $574K | ﹤0.01% |
49,970
| – | – |
|
1496
Eagle Bancorp
EGBN
$592M
| $573K | ﹤0.01% |
21,400
| – | – |
|
|
GTM
1497
ZoomInfo Technologies
GTM
$3.28B
| $573K | ﹤0.01% |
13,319
-36,681
| -73% | -$1.58M |
|
1498
Match Group
MTCH
$9.03B
| $570K | ﹤0.01% |
+5,155
| New | +$570K |
|
1499
Anika Therapeutics
ANIK
$129M
| $566K | ﹤0.01% |
16,000
| – | – |
|
|
MDP
1500
DELISTED
Meredith Corporation
MDP
| $564K | ﹤0.01% |
42,970
| – | – |
|